SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The LAPTOP.X token is trending following a rapid and significant value collapse immediately after its launch, which the community widely characterizes as a "rug pull." Investors are expressing frustration and ridicule over the token's extreme volatility and its status as a speculative meme coin.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as traders focus on upcoming clinical trial data presentations and the regulatory path for its lead drug, ivonescimab. While sentiment remains broadly bullish due to recent positive overall survival data and heavy insider accumulation, some community members express caution regarding the regulatory risk, potential dilution, and the competitive landscape with established cancer therapies.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing significant selling pressure following the announcement that its co-founders will step down by the end of the year to start a new venture, alongside a reported quarterly loss and revenue guidance that fell short of analyst expectations. Traders are expressing skepticism toward the company's transition and the lack of a clear successor, while some look to the remaining oncology pipeline as a potential long-term value play.

Pons

The conversation surrounding PONS is heavily dominated by discussions regarding recent price volatility and speculation over a large short position that traders are attempting to squeeze. Community sentiment is also focused on the ecosystem's expansion, specifically the launch of new tokens like MONEYDOG, which some users characterize as a reward for PONS holders.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

The community is heavily focused on the narrative that DebtReliefBot is an AI-generated token connected to Elon Musk's Grok AI and the Bankr ecosystem, frequently citing "Grok has money" as a bullish catalyst. Traders express optimism regarding its potential for massive growth, often pointing to thin supply on exchanges and the token's presence on the Base chain as reasons for potential price appreciation.

NetApp, Inc. engages in the provision of software, systems, and services to manage and share data on-premises. The firm also offers private and public clouds worldwide. It operates through the Hybrid Cloud and Public Cloud segments. The Hybrid Cloud segment provides a data storage portfolio for storage management and infrastructure solutions. The Public Cloud segment refers to a portfolio of products delivered primarily as-a-service. The company was founded by David Hitz, James K. Lau, and Michael Malcolm in April 1992 and is headquartered in San Jose, CA.

Netapp Inc

NetApp is trending following a record fiscal first-quarter earnings report that featured double-digit year-over-year growth in revenue and all-flash storage sales, alongside a significantly raised full-year guidance. Traders are debating the valuation disconnect as the company positions itself as a key AI data infrastructure player, with many expressing frustration over initial market volatility and perceived irrational selling pressure.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending as market sentiment remains cautious amid broader economic concerns, including rising inflation, high interest rates, and geopolitical tensions in the Middle East. Traders are actively discussing the impact of institutional rotation and potential market volatility as investors weigh the sustainability of the current AI-led bull run against macroeconomic headwinds.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as users express significant frustration over repeated technical outages and platform glitches that have prevented trade execution. While some traders discuss the company's long-term growth potential and recent 52-week highs, current sentiment is heavily weighed down by negative experiences with its trading applications, prompting some to consider migrating to competing brokerages.

Chip

Traders are actively debating the long-term potential of the token, with supporters highlighting its role in AI infrastructure financing and GPU-backed credit, while detractors characterize it as a pump-and-dump scheme experiencing sustained downward price pressure. Sentiment remains polarized between those accumulating at current price levels in anticipation of a breakthrough and those expressing frustration over ongoing volatility and the project's circulating supply.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending amidst a mix of intense bearish sentiment from traders expecting further price declines and speculative debate over its future utility and long-term valuation. Discussion is fragmented between vocal critics calling the token worthless and retail investors attempting to identify bottom-entry points during periods of high volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech Radar July 28, 2026: Kiniksa Rerates, Nautilus Pushes Voyager Shipments to Mid-2027 and Alkermes Expands Its Sleep Franchise — $KNSA $NAUT $ALKS  https://www.merlintrader.com/biotech-radar-july28-2026/

David B

Today's Radar separates a genuine commercial-plus-clinical rerating at Kiniksa from a material commercialization-timeline reset at Nautilus Biotechnology and a strong but more complex post-acquisition quarter at Alkermes. NeoGenomics and Mirion remain on the closing-bell watchlist, with results scheduled after the market closes.

Merlintrader Trading Pub

Biotech Radar July 28, 2026: Kiniksa Rerates, Nautilus Pushes Voyager Shipments To Mid-2027 And Alkermes Expands Its Sleep Franchise - $KNSA $NAUT $ALKS - Merlintrader Trading Pub

StockTwits Web

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Nautilus Biotechnology Inc

Alkermes plc

Biotech Radar July 28, 2026: Kiniksa Rerates, Nautilus Pushes Voyager Shipments to Mid-2027 and Alkermes Expands Its Sleep Franchise — 